355 related articles for article (PubMed ID: 10725717)
21. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
Sugiura T; Kawaguchi Y; Harigai M; Takagi K; Ohta S; Fukasawa C; Hara M; Kamatani N
J Immunol; 2000 Jun; 164(12):6593-600. PubMed ID: 10843719
[TBL] [Abstract][Full Text] [Related]
22. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.
Bauditz J; Wedel S; Lochs H
Gut; 2002 Feb; 50(2):196-200. PubMed ID: 11788559
[TBL] [Abstract][Full Text] [Related]
23. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
24. IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation.
Luft T; Jefford M; Luetjens P; Hochrein H; Masterman KA; Maliszewski C; Shortman K; Cebon J; Maraskovsky E
J Immunol; 2002 Jan; 168(2):713-22. PubMed ID: 11777965
[TBL] [Abstract][Full Text] [Related]
25. CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms.
Kuroiwa T; Lee EG; Danning CL; Illei GG; McInnes IB; Boumpas DT
J Immunol; 1999 Aug; 163(4):2168-75. PubMed ID: 10438958
[TBL] [Abstract][Full Text] [Related]
26. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
Yamauchi PS; Bleharski JR; Uyemura K; Kim J; Sieling PA; Miller A; Brightbill H; Schlienger K; Rea TH; Modlin RL
J Immunol; 2000 Aug; 165(3):1506-12. PubMed ID: 10903757
[TBL] [Abstract][Full Text] [Related]
27. In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts.
Bregenholt S; Brimnes J; Nissen MH; Claesson MH
Clin Exp Immunol; 1999 Nov; 118(2):228-34. PubMed ID: 10540183
[TBL] [Abstract][Full Text] [Related]
28. IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation.
Avice MN; Demeure CE; Delespesse G; Rubio M; Armant M; Sarfati M
J Immunol; 1998 Oct; 161(7):3408-15. PubMed ID: 9759858
[TBL] [Abstract][Full Text] [Related]
29. Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.
Ebert EC; Mehta V; Das KM
Clin Exp Immunol; 2005 Apr; 140(1):157-65. PubMed ID: 15762887
[TBL] [Abstract][Full Text] [Related]
30. Differential induction of IL-1beta and TNF by CD40 ligand or cellular contact with stimulated T cells depends on the maturation stage of human monocytes.
Burger D; Molnarfi N; Gruaz L; Dayer JM
J Immunol; 2004 Jul; 173(2):1292-7. PubMed ID: 15240722
[TBL] [Abstract][Full Text] [Related]
31. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
[TBL] [Abstract][Full Text] [Related]
32. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
33. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12.
Cong Y; Weaver CT; Lazenby A; Elson CO
J Immunol; 2000 Aug; 165(4):2173-82. PubMed ID: 10925304
[TBL] [Abstract][Full Text] [Related]
34. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases.
Sarra M; Monteleone I; Stolfi C; Fantini MC; Sileri P; Sica G; Tersigni R; Macdonald TT; Pallone F; Monteleone G
Inflamm Bowel Dis; 2010 Aug; 16(8):1332-9. PubMed ID: 20186935
[TBL] [Abstract][Full Text] [Related]
35. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
[TBL] [Abstract][Full Text] [Related]
36. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.
Liu Z; Geboes K; Colpaert S; Overbergh L; Mathieu C; Heremans H; de Boer M; Boon L; D'Haens G; Rutgeerts P; Ceuppens JL
J Immunol; 2000 Jun; 164(11):6005-14. PubMed ID: 10820284
[TBL] [Abstract][Full Text] [Related]
37. The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease.
Borcherding F; Nitschke M; Hundorfean G; Rupp J; von Smolinski D; Bieber K; van Kooten C; Lehnert H; Fellermann K; Büning J
Am J Pathol; 2010 Apr; 176(4):1816-27. PubMed ID: 20133813
[TBL] [Abstract][Full Text] [Related]
38. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.
Schreiber S; Heinig T; Panzer U; Reinking R; Bouchard A; Stahl PD; Raedler A
Gastroenterology; 1995 Jan; 108(1):21-33. PubMed ID: 7806044
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of IL-16 in inflammatory bowel disease.
Seegert D; Rosenstiel P; Pfahler H; Pfefferkorn P; Nikolaus S; Schreiber S
Gut; 2001 Mar; 48(3):326-32. PubMed ID: 11171821
[TBL] [Abstract][Full Text] [Related]
40. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.
Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G
J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
